Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma

References

• Kademani D. Oral cancer. Mayo Clin Proc 2007; 82:878-87; PMID:17605971; http://dx.doi.org/10.4065/82.7.878
   PubMed Web of Science ®Google Scholar
• Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45:309-16; PMID:18804401; http://dx.doi.org/10.1016/j.oraloncology.2008.06.002
   PubMed Web of Science ®Google Scholar
• Schliephake H. Prognostic relevance of molecular markers of oral cancer–a review. Int J Oral Maxillofac Surg 2003; 32:233-45; PMID:12767868; http://dx.doi.org/10.1054/ijom.2002.0383
   PubMed Web of Science ®Google Scholar
• Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26:1324-37; PMID:17322918; http://dx.doi.org/10.1038/sj.onc.1210220
   PubMed Web of Science ®Google Scholar
• Uren AG, Pakusch M, Hawkins CJ, Puls KL, Vaux DL. Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci U S A 1996; 93:4974-8; PMID:8643514; http://dx.doi.org/10.1073/pnas.93.10.4974
   PubMed Web of Science ®Google Scholar
• Chiou SK, Jones MK, Tarnawski AS. Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 2003; 9:Pi25-9; PMID:12709681
   PubMedGoogle Scholar
• Blanc-Brude OP. Mesri M, Wall NR, Plescia J, Dohi T, Altieri DC. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res 2003; 9:2683-92; PMID:12855648
   PubMed Web of Science ®Google Scholar
• Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 2001; 40:1117-23; PMID:11170436; http://dx.doi.org/10.1021/bi001603q
   PubMed Web of Science ®Google Scholar
• Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22:8581-9; PMID:14634620; http://dx.doi.org/10.1038/sj.onc.1207113
   PubMed Web of Science ®Google Scholar
• O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS, Altieri DC. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Patho 2000; 156:393-8; http://dx.doi.org/10.1016/S0002-9440(10)64742-6
   PubMed Web of Science ®Google Scholar
• Altieri DC. Validating survivin as a cancer therapeutic target. Nat Rev Cancer 2003; 3:46-5; PMID:12509766; http://dx.doi.org/10.1038/nrc968
   PubMed Web of Science ®Google Scholar
• Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3:917-21; PMID:9256286; http://dx.doi.org/10.1038/nm0897-917
   PubMed Web of Science ®Google Scholar
• Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res 2004; 64:7183-90; PMID:15492230; http://dx.doi.org/10.1158/0008-5472.CAN-04-1918
   PubMed Web of Science ®Google Scholar
• Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 2005; 114:509-12; PMID:15578717; http://dx.doi.org/10.1002/ijc.20768
   PubMed Web of Science ®Google Scholar
• Ling X, Yang J, Tan D, Ramnath N, Younis T, Bundy BN, Slocum HK, Yang L, Zhou M, Li F. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC). Lung Cancer 2005; 49:353-61; PMID:15936846; http://dx.doi.org/10.1016/j.lungcan.2005.03.037
   PubMed Web of Science ®Google Scholar
• Lu B, Gonzalez A, Massion PP, Shyr Y, Shaktour B, Carbone DP, Hallahan DE. Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer 2004; 91:537-40; PMID:15266313; http://dx.doi.org/10.1038/sj.bjc.6602027
   PubMed Web of Science ®Google Scholar
• Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Freyer AS, Olson SJ, Andersen JJ, Shyr Y, Carbone DP, et al. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer 2005; 103:1685-92; PMID:15742356; http://dx.doi.org/10.1002/cncr.20951
   PubMed Web of Science ®Google Scholar
• Vischioni B, van der Valk P, Span SW, Kruyt FA, Rodriguez JA, Giaccone G. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer. Ann Oncol 2004; 15:1654-60; PMID:15520067; http://dx.doi.org/10.1093/annonc/mdh436
   PubMed Web of Science ®Google Scholar
• Peng CH, Liao CT, Peng SC, Chen YJ, Cheng AJ, Juang JL, Tsai CY, Chen TC, Chuang YJ, Tang CY, et al. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PloS One 2011; 6:e23452; PMID:21853135; http://dx.doi.org/10.1371/journal.pone.0023452
   PubMedGoogle Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Wang H, Holloway MP, Ma L, Cooper ZA, Riolo M, Samkari A, Elenitoba-Johnson KS, Chin YE, Altura RA. Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity. J Biol Chem 2010; 285:36129-37; PMID:20826784; http://dx.doi.org/10.1074/jbc.M110.152777
   PubMed Web of Science ®Google Scholar
• Fukuda S, Pelus LM. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 2001; 98:2091-100; PMID:11567995; http://dx.doi.org/10.1182/blood.V98.7.2091
   PubMed Web of Science ®Google Scholar
• Chiou SK, Moon WS, Jones MK, Tarnawski AS. Survivin expression in the stomach: implications for mucosal integrity and protection. Biochem Biophys Res Commun 2003; 305:374-9; PMID:12745085; http://dx.doi.org/10.1016/S0006-291X(03)00724-1
   PubMed Web of Science ®Google Scholar
• Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000; 96:1921-5; PMID:10961895
   PubMed Web of Science ®Google Scholar
• Azuhata T, Scott D, Takamizawa S, Wen J, Davidoff A, Fukuzawa M, Sandler A. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. J Pediatr Surg 2001; 36:1785-91; PMID:11733907; http://dx.doi.org/10.1053/jpsu.2001.28839
   PubMed Web of Science ®Google Scholar
• Ikeguchi M, Liu J, Kaibara N. Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis 2002; 7:23-9; PMID:11773702; http://dx.doi.org/10.1023/A:1013556727182
   PubMed Web of Science ®Google Scholar
• Kim YH, Kim SM, Kim YK, Hong SP, Kim MJ, Myoung H. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma. J Oral Pathol Med 2010; 39:368-75; PMID:20050981
   PubMed Web of Science ®Google Scholar
• Iyer SG, Pradhan SA, Pai PS, Patil S. Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa. Head Neck 2004; 26:897-902; PMID:15390193; http://dx.doi.org/10.1002/hed.20096
   PubMed Web of Science ®Google Scholar
• Rao DN, Shroff PD, Chattopadhyay G, Dinshaw KA. Survival analysis of 5595 head and neck cancers–results of conventional treatment in a high-risk population. Br J Cancer 1998; 77:1514-8; PMID:9652771; http://dx.doi.org/10.1038/bjc.1998.249
   PubMed Web of Science ®Google Scholar
• Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M, Linehan R, Clynes M. Prognostic importance of survivin in breast cancer. Br J Cancer 2003; 88:1077-83; PMID:12671708; http://dx.doi.org/10.1038/sj.bjc.6600776
   PubMed Web of Science ®Google Scholar
• Lehner R, Lucia MS, Jarboe EA, Orlicky D, Shroyer AL, McGregor JA, Shroyer KR. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 2002; 10:134-8; PMID:12051631
   PubMedGoogle Scholar
• Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 2001; 163:109-16; PMID:11163114; http://dx.doi.org/10.1016/S0304-3835(00)00677-7
   PubMed Web of Science ®Google Scholar
• Trieb K, Lehner R, Stulnig T, Sulzbacher I, Shroyer KR. Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol 2003; 29:379-82; PMID:12711293; http://dx.doi.org/10.1053/ejso.2002.1415
   PubMed Web of Science ®Google Scholar
• Grabowski P, Kühnel T, Mühr-Wilkenshoff F, Heine B, Stein H, Höpfner M, Germer CT, Scherübl H. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 2003; 88:115-9; PMID:12556969; http://dx.doi.org/10.1038/sj.bjc.6600696
   PubMed Web of Science ®Google Scholar
• Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC, Altieri DC. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 2002; 115:575-85; PMID:11861764
   PubMed Web of Science ®Google Scholar
• Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gabbert HE, Gerharz CD. Differential subcellular localization of functionally divergent survivin splice variants. Cell Death Differ 2002; 9:1334-42; PMID:12478470; http://dx.doi.org/10.1038/sj.cdd.4401091
   PubMed Web of Science ®Google Scholar
• De Maria S, Pannone G, Bufo P, Santoro A, Serpico R, Metafora S, Rubini C, Pasquali D, Papagerakis SM, Staibano S, et al. Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol 2009; 135:107-16; PMID:18642030; http://dx.doi.org/10.1007/s00432-008-0433-z
   PubMed Web of Science ®Google Scholar
• Barrett RM, Colnaghi R, Wheatley SP. Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro. Cell Cycle 2011; 10:538-48; PMID:21252625; http://dx.doi.org/10.4161/cc.10.3.14758
   PubMed Web of Science ®Google Scholar
• Colnaghi R, Wheatley SP. Liaisons between survivin and Plk1 during cell division and cell death. J Biol Chem 2010; 285:22592-604; PMID:20427271; http://dx.doi.org/10.1074/jbc.M109.065003
   PubMed Web of Science ®Google Scholar
• Nousiainen M, Silljé HH, Sauer G, Nigg EA, Körner R. Phosphoproteome analysis of the human mitotic spindle. Proc Natl Acad Sci U S A 2006; 103:5391-6; PMID:16565220; http://dx.doi.org/10.1073/pnas.0507066103
   PubMed Web of Science ®Google Scholar
• Wheatley SP, Barrett RM, Andrews PD, Medema RH, Morley SJ, Swedlow JR, Lens SM. Phosphorylation by aurora-B negatively regulates survivin function during mitosis. Cell Cycle 2007; 6:1220-30; PMID:17457057; http://dx.doi.org/10.4161/cc.6.10.4179
   PubMed Web of Science ®Google Scholar
• O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC, Altieri DC. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 2000; 97:13103-7; PMID:11069302; http://dx.doi.org/10.1073/pnas.240390697
   PubMed Web of Science ®Google Scholar
• Nogueira-Ferreira R, Vitorino R, Ferreira-Pinto MJ, Ferreira R, Henriques-Coelho T. Exploring the role of post-translational modifications on protein-protein interactions with survivin. Arch Biochem Biophys 2013; 538:64-70; PMID:23938875; http://dx.doi.org/10.1016/j.abb.2013.07.027
   PubMed Web of Science ®Google Scholar
• Zhu Y, Gu YX, Mo JJ, Shi JY, Qiao SC, Lai HC. N-acetyl cysteine protects human oral keratinocytes from Bis-GMA-induced apoptosis and cell cycle arrest by inhibiting reactive oxygen species-mediated mitochondrial dysfunction and the PI3K/Akt pathway. Toxicol In Vitro 2015; 29:2089-101; PMID:26343756; http://dx.doi.org/10.1016/j.tiv.2015.09.002
   PubMed Web of Science ®Google Scholar
• Liu SL, Zhong SS, Ye DX, Chen WT, Zhang ZY, Deng J. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma. J Oral Pathol Med 2013; 42:761-8; PMID:23651229; http://dx.doi.org/10.1111/jop.12077
   PubMed Web of Science ®Google Scholar
• Liu S, Ye D, Guo W, Yu W, He Y, Hu J, Wang Y, Zhang L, Liao Y, Song H, et al. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget 2015; 6:6887-901; PMID:25749385; http://dx.doi.org/10.18632/oncotarget.3159
   PubMed Web of Science ®Google Scholar
• Liu S, Liu L, Ye W, Ye D, Wang T, Guo W, Liao Y, Xu D, Song H, Zhang L, et al. High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma. Sci Rep 2016; 6:38834; PMID:27966589; http://dx.doi.org/10.1038/srep38834
   PubMed Web of Science ®Google Scholar
• Li J, Zhou BP. Activation of beta-catenin and Akt pathways by Twist are critical for the maintenance of EMT associated cancer stem cell-like characters. BMC Cancer 2011; 11:49; PMID:21284870; http://dx.doi.org/10.1186/1471-2407-11-49
   PubMed Web of Science ®Google Scholar
• Zhong S, Yin H, Liao Y, Yao F, Li Q, Zhang J, Jiao H, Zhao Y, Xu D, Liu S, et al. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling. Cancer Res 2015; 75:1801-14; PMID:25744720; http://dx.doi.org/10.1158/0008-5472.CAN-14-2005
   PubMed Web of Science ®Google Scholar